Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$25.93 USD
-0.50 (-1.89%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $25.93 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Royal Philips (PHG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$30.00 | $35.00 | $25.00 | 13.51% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Royal Philips comes to $30.00. The forecasts range from a low of $25.00 to a high of $35.00. The average price target represents an increase of 13.51% from the last closing price of $26.43.
Analyst Price Targets (2 )
Broker Rating
Royal Philips currently has an average brokerage recommendation (ABR) of 2.63 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.63 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, two are Strong Buy, representing 25% of all recommendations. A month ago, Strong Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 1 |
ABR | 2.63 | 2.63 | 2.63 | 2.63 | 3.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/13/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/7/2024 | Not Identified | Not Identified | Moderate Sell | Moderate Sell |
5/6/2024 | Exane BNP Paribas | Hugo Solvet | Strong Sell | Hold |
4/30/2024 | UBS | Graham Doyle | Strong Sell | Hold |
3/29/2024 | Goldman Sachs | Richard Felton | Strong Buy | Strong Buy |
10/24/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.63 |
ABR (Last week) | 2.63 |
# of Recs in ABR | 8 |
Average Target Price | $30.00 |
LT Growth Rate | 18.10% |
Industry | Medical - Products |
Industry Rank by ABR | 98 of 252 |
Current Quarter EPS Est: | NA |